{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-044912","form_type":"8-K","ticker":"STIM","cik":"0001227636","company_name":"Neuronetics, Inc.","filed_at":"2026-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.665399+00:00","generated_at":"2026-05-16T03:31:35.858579+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Neuronetics reports preliminary Q4 2025 revenue $41.8M, up 23% pro forma; positive operating cash flow","bullets":["Q4 revenue $41.8M, 23% YoY pro forma growth; NeuroStar revenue $18.3M (+9% pro forma).","Full year 2025 revenue $149.2M, 15% pro forma growth; clinic revenue $87.0M (+28% pro forma).","Q4 operating cash flow positive $0.9M; total cash $34.1M at year-end.","49 NeuroStar systems shipped in Q4.","Final Q4 results to be released March 17, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-044912","json":"https://secwatch.observer/filing/0001193125-26-044912.json","markdown":"https://secwatch.observer/filing/0001193125-26-044912.md","text":"https://secwatch.observer/filing/0001193125-26-044912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526044912/0001193125-26-044912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526044912/d109652d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:31:35.858579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}